Associate Professor, Institute for Cellular Research at the University of Minnesota, Dr. Dan Kaufmann said, "Not only human embryonic stem cell research, but also unethical, but also important progress in biomedical research has made significant progress, Current therapy ... (thesurvivaldoctor.com) Effective treatment of the disease. "Whether these benefits outweigh relevant risks, I think stem cell research, public research finish is complete Believe that access is necessary in order to need to develop to understand whether diseases can be cured by stem cells.
The basis of stem cell biology starts with the definition of stem cells. Broadly, stem cells are cells with two important functions: 1) self-renewal and 2) differentiation, or conversion to another cell. Self replication means that cells divide, proliferate, and number increase. Differentiation is the process of converting stem cells to another more specialized cell. This example is a hematopoietic stem cell, or a blood stem cell present in the bone marrow, split to differentiate into white blood cells to gain a number (self renewal) and then a warning immune response (to obtain: The lineage is known via the ancestral group then you enter the terminal differentiated cell)
Pluripotent stem cells are present in the bone marrow of living humans. In the bone marrow, these stem cells are responsible for the production of red blood cells and white blood cells. These cells can actually be transplanted from one person to another as long as the blood type is consistent with other factors, to help cure certain diseases and blood disorders. For example, leukemia and lymphoma. The goal of stem cell research is to study the process of human development, hoping to better understand the reasons for ending with specific malformations and diseases such as cancer. Pluripotent stem cells can be designed as cells or organs to replace living human defective or nonfunctional stem cells. In the future, transplant organ donors may not have to wait for a long time. In the short term scientists are considering the use of these stem cells, tissues or organ transplant bridges to reduce the likelihood of rejection of their host body.